Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes.
about
CD36 protein is involved in store-operated calcium flux, phospholipase A2 activation, and production of prostaglandin E2CD36: implications in cardiovascular diseasePlasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetesEmerging role of mast cells and macrophages in cardiovascular and metabolic diseasesPhagocytosis of cholesteryl ester is amplified in diabetic mouse macrophages and is largely mediated by CD36 and SR-A.Deregulation of inflammatory response in the diabetic condition is associated with increased ischemic brain injury.CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes.Increased CD36 expression signals monocyte activation among patients with type 2 diabetes.CD36 as a therapeutic target for endothelial dysfunction in stroke.Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes.Transcriptional regulation of fatty acid translocase/CD36 expression by CCAAT/enhancer-binding protein alphaCommon sequence variants in CD36 gene and the levels of triglyceride and high-density lipoprotein cholesterol among ethnic Chinese in TaiwanDifferential lipid metabolism in monocytes and macrophages: influence of cholesterol loadingProperties of human blood monocytes. I. CD91 expression and log orthogonal light scatter provide a robust method to identify monocytes that is more accurate than CD14 expression.Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterolInvestigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver diseaseCD36: a multi-modal target for acute stroke therapy.Soluble CD36- a marker of the (pathophysiological) role of CD36 in the metabolic syndrome?Increased CD36 protein as a response to defective insulin signaling in macrophagesHyperglycemia suppresses hepatic scavenger receptor class B type I expression.Oxidised LDL up-regulate CD36 expression by the Nrf2 pathway in 3T3-L1 preadipocytes.Modulation of human monocyte CD36 by type 2 diabetes mellitus and other atherosclerotic risk factors.Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men.Cariporide counteracts atherosclerosis-related functions in monocytes from obese and normal individuals.Vitamin D3 supplementation decreases a unique circulating monocyte cholesterol pool in patients with type 2 diabetes.Training-induced anti-atherosclerotic effects are associated with increased vascular PPARgamma expression in apolipoprotein E-deficient mice.9- and 13-HODE regulate fatty acid binding protein-4 in human macrophages, but does not involve HODE/GPR132 axis in PPAR-γ regulation of FABP4.Hemodialysis-related changes in phenotypical features of monocytes
P2860
Q24634132-EB34E603-1B59-4079-BEA7-99C4AFDAF7B0Q24678338-EBE6F4AF-CF98-425A-BCA3-B38E1A881751Q24798147-C64061FF-EFC3-45D9-90CA-039976A085EFQ26825467-436903A6-F8CC-432B-BCD3-2258CF1A6EB2Q33286823-03B48FD4-4E2B-4B97-89A6-6CCB9DB8E353Q33597860-02736A13-553D-488C-B59F-2D1DAA46115FQ33916537-FD2187F2-6CC6-44A7-BFA9-D5E93BB981DFQ34084613-66878B61-E19C-443C-BB2E-84C3A5EA287DQ36139754-266AF725-8E80-4432-B3B3-76C6823B2C5DQ36288862-BE4FBECF-E0A4-4153-8F01-51AE2A1803FEQ36512154-A436650D-989B-4971-A9DC-56D61506D3FFQ36618298-B87906C7-C11D-4499-88AE-C0056C170F43Q36731741-618A4093-AB51-4D84-AEFB-C473D172A9C6Q36862828-E71F3266-6ADC-4107-985A-CC3FFA3A4434Q37127230-650D5D87-2728-42E9-ADCA-B59982F6AF77Q37356254-76179A8C-8D0E-4D08-B102-532CFA08CB7EQ37459051-142C82AF-3924-4CBB-9EF5-2F19AFE8F1A9Q37830690-12451421-91C4-453C-897D-CC236EBC6B7AQ38344254-8B537802-458D-4155-9E55-CA35DF68A39CQ40063386-BD967CA7-6224-4E3D-BDB4-052AB846088BQ42812312-A3877A9A-549C-44C2-B483-9A496473F99EQ45156504-90A8096E-A6E5-4717-BBC0-084488D379A4Q46155246-C44EF52C-5ED9-4E30-8638-C18D10197D25Q46750270-F693A0CB-D404-40DA-B7CC-934EAD6F1AA3Q47754132-08BFB80F-D143-4820-BCE5-C73680621D29Q53311171-D9279377-D066-468A-BE93-FD39A5063C35Q55135310-64B86D9F-BE1B-4781-BC91-BC9A9F361E41Q58726638-D59B1708-9D40-4DC4-AD47-059ED5386110
P2860
Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Increased expression of a scav ...... subjects with Type 2 diabetes.
@ast
Increased expression of a scav ...... subjects with Type 2 diabetes.
@en
type
label
Increased expression of a scav ...... subjects with Type 2 diabetes.
@ast
Increased expression of a scav ...... subjects with Type 2 diabetes.
@en
prefLabel
Increased expression of a scav ...... subjects with Type 2 diabetes.
@ast
Increased expression of a scav ...... subjects with Type 2 diabetes.
@en
P2093
P1433
P1476
Increased expression of a scav ...... subjects with Type 2 diabetes.
@en
P2093
David A Hughes
Isabel R Davies
Kamal Ivory
Michael J Sampson
Simon Braschi
P304
P356
10.1016/S0021-9150(02)00421-5
P577
2003-03-01T00:00:00Z